FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form...

Published on 5 Dec 2024 on Benzinga · via Yahoo Finance

On Thursday, the FDA approved AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) for adult patients...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In...

Insider Monkey · via Yahoo Finance 17 Dec 2024

The Institute for Clinical and Economic Review (ICER) has identified five prescription drugs whos...

Benzinga · via Yahoo Finance 13 Dec 2024

AstraZeneca Plc (NASDAQ:AZN) and Merck & Co Inc (NYSE:MRK), on Wednesday, announced long-term...

Benzinga · via Yahoo Finance 11 Dec 2024

* Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $504,097!* Right...thr...

Motley Fool · via Yahoo Finance 10 Dec 2024

We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In...

Insider Monkey · via Yahoo Finance 10 Dec 2024

Astrazeneca (AZN) AstraZeneca plc, headquartered in London, UK, is one of the largest...

Zacks · via Yahoo Finance 10 Dec 2024

Year to date, Pfizer’s stock has declined 10.7%. Pfizer beat estimates in each of the last four...

Zacks · via Yahoo Finance 9 Dec 2024

For those who like to find small cap companies at attractive valuations, this free list of growin...

Simply Wall St. · via Yahoo Finance 8 Dec 2024

Some better-ranked stocks from the biotech sector are Immunocore Holdings plc IMCR, Spero...

Zacks · via Yahoo Finance 6 Dec 2024

On Thursday, the FDA approved AstraZeneca Plc's (NASDAQ:AZN) Imfinzi (durvalumab) for adult patie...

Benzinga · via Yahoo Finance 5 Dec 2024